Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02714
Species: Homo sapiens
Position : chr16:163380-163907
Year: 2017
Title: Editing an 汐-globin enhancer in primary human hematopoietic stem cells as a treatment for 汕-thalassemia.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: alpha thalassemia spectrum
PMID:  28871148
MONDO: MONDO:0011399
Tissue: blood
Tissue Ontology ID: UBERON:0000178
Cell Source: Primary human CD34+ HSPC-derived erythroid cells
Cell Type: erythroid progenitor cell
Cell Ontology ID: CL:0000038
Experiment Type: Enhancer activity assay; TF binding assay; Functional perturbation assay; Gene expression assay; Chromatin-state assay
High Throughput Method: ChIP-seq
Low Throughput Method: CRISPR-Cas9 MCS-R2 deletion; Sanger sequencing; droplet digital PCR; RT-qPCR; TAL1/SCL ChIP-qPCR; xenograft assay; CRISPR-Cas9
About Target Gene
Target gene : HBA2
About TF
TF name : TAL1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 5 found
Enhancer ID Position Tissue Cell Disease
E_02424 chr16:163380-163907 pleural effusion erythroid lineage cell NA
E_02425 chr16:163380-163907 pleural effusion erythroid lineage cell NA
E_02713 chr16:163380-163907 blood erythroid progenitor cell alpha thalassemia spectrum
E_03501 chr16:163406-163841 blood erythroblast NA
E_03502 chr16:163406-163841 blood erythroblast NA
Expression of Target Genes for the Enhancer